Cancer Research UK

Being dependent on its high street shops and income from sponsored events meant CRUK was very hard hit by lockdowns. Now it is launching a new science strategy to reinvigorate research and promote closer ties with industry

The world’s largest cancer charity expects its income to fall by £350M over the next three years

Outcome-based pricing of cancer drugs could provide savings for payers and patients, but generating enough data on benefits remains a big challenge